Swiss All Share Index
15.742,25
PKT
+45,66
PKT
+0,29
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
23.12.22 | Roche Overweight | Barclays Capital | |
21.12.22 | UBS Outperform | RBC Capital Markets | |
20.12.22 | Richemont Overweight | JP Morgan Chase & Co. | |
20.12.22 | UBS Sector Perform | RBC Capital Markets | |
20.12.22 | DocMorris Sell | UBS AG | |
19.12.22 | Nestlé Neutral | Credit Suisse Group | |
19.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
19.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
19.12.22 | Givaudan Sell | UBS AG | |
16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
16.12.22 | Givaudan Sell | Goldman Sachs Group Inc. | |
16.12.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
15.12.22 | Givaudan Hold | Deutsche Bank AG | |
15.12.22 | UBS Buy | Goldman Sachs Group Inc. | |
14.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
14.12.22 | Givaudan Underweight | JP Morgan Chase & Co. | |
14.12.22 | Novartis Neutral | UBS AG | |
14.12.22 | Roche Neutral | UBS AG | |
13.12.22 | Nestlé Neutral | Credit Suisse Group | |
13.12.22 | Givaudan Sell | UBS AG | |
12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
09.12.22 | DocMorris Add | Baader Bank | |
09.12.22 | Novartis Sell | Deutsche Bank AG | |
09.12.22 | DocMorris Buy | Warburg Research | |
09.12.22 | Givaudan Underperform | Jefferies & Company Inc. | |
09.12.22 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
09.12.22 | UBS Neutral | Credit Suisse Group | |
08.12.22 | Novartis Market-Perform | Bernstein Research | |
08.12.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
08.12.22 | Richemont Conviction Buy List | Goldman Sachs Group Inc. | |
08.12.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
08.12.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
08.12.22 | Swiss Re Overweight | JP Morgan Chase & Co. | |
07.12.22 | Novartis Sell | Deutsche Bank AG | |
06.12.22 | UBS Overweight | JP Morgan Chase & Co. | |
06.12.22 | Novartis Neutral | UBS AG | |
05.12.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
05.12.22 | Nestlé Market-Perform | Bernstein Research | |
05.12.22 | UBS Buy | Jefferies & Company Inc. | |
02.12.22 | Swiss Re Sell | UBS AG |